Chief medical officers from leading global reinsurance companies will explore the latest advancements in medical science and their potential impacts on mortality trends. They'll delve into how these innovations are reshaping risk selection strategies, offering fresh insights into the evolving landscape of the insurance industry. Attendees can expect a deep dive into cutting-edge research and practical applications that promise to revolutionize the field.